Pulmonary capillary hemangiomatosis (PCH) is a rare and controversial entity that is known to be a cause of pulmonary hypertension and is microscopically characterized by proliferation of dilated capillary-sized channels along and in the alveolar walls. Clinically, it is mostly seen in adults. Clinical features are characterized by nonspecific findings such as shortness of breath, cough, chest pain, and fatigue. It can be clinically indistinguishable from pre-capillary pulmonary arterial hypertension disorders such as primary pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension. However, the diagnostic distinction, which usually requires a multidisciplinary approach, is crucial in order to avoid inappropriate treatment with vasodilator medications usually used for PAH treatment. Prognosis of PCH remains poor with lung transplant being the only definitive treatment. We report an autopsy case of pulmonary capillary hemangiomatosis unmasked at autopsy that was treated with a prostacyclin analog, usually contraindicated in such patients. We emphasize that this entity should always be on the differential diagnosis in a patient with pulmonary hypertension and requires great vigilance on the part of the clinician, radiologist and pathologist to make the diagnosis and guide appropriate management.
AlmagroP, JuliaJ, SanjaumeM, et al. Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature. Medicine. 2002;81(6):417-24. [https://doi.org/10.1097/00005792-200211000-00002]. [PMID:12441898]
LantuéjoulS, SheppardMN, CorrinB, BurkeMM, NicholsonAG. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathology study of 35 cases. Am J Surg Pathol. 2006;30(7):850-7. [https://doi.org/10.1097/01.pas.0000209834.69972.e5]. [PMID:16819327]
De MontprévilleVT, DulmetÉ, FadelÉ, DartevelleP. Lymph node pathology in pulmonary veno-occlusive disease and pulmonary capillary heamangiomatosis. Virchows Arch. 2008;453(2):171-6. [https://doi.org/10.1007/s00428-008-0636-3]. [PMID:18551306]
VelasquezL, JagirdarJ, RiddleN. Association of prominent lymphadenopathy with pulmonary capillary hemangiomatosis and severe pulmonary hypertension in a 3-year-old child. Am J Clin Pathol. 2016;146(Suppl 1). [https://doi.org/10.1093/ajcp/aqw159.029].
TunariuN, GibbsSJ, WinZ, et al. V Ventilation-perfustion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48(5):680-4. [https://doi.org/10.2967/jnumed.106.039438]. [PMID:17475953]
GüttingerE, VrugtB, SpeichR, et al. Reactive pulmonary capillary hemangiomatosis and pulmonary veno-occlusive disease in a patient with repaired Scimitar syndrome. Case Rep Cardiol. 2016;2016:9384126. [https://doi.org/10.1155/2016/9384126]. [PMID:27069695]
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email